KGMU docs’ white paper on Ivermectin on WHO site
TIMES NEWS NETWORK
Lucknow: 07.10.2020
A white paper on Ivermectin drug as potential therapy for Covid-19 prepared by head of KGMU’s respiratory medicine department Prof Surya Kant and other senior doctors from different states of India has found recognition by the World Health Organization (WHO). The paper published in the Indian Journal of Tuberculosis Elsevier is now a part of the global literature on Covid-19, getting space on WHO’s website.
The abstract of the article states that “A group of senior doctors with vast clinical experience met on July 19, 2020, under the aegis of the Academy of Advanced Medical Education. The panel looked at Ivermectin, one of the old molecules and evaluated its use in Covid-19 management. After critical panel discussion, all the attending doctors came to a conclusion that Ivermectin can be a potential molecule for prophylaxis and treatment of people infected with novel coronavirus owing to its “anti-viral properties coupled with effective cost, availability and good tolerability and safety.”
Along with KGMU, Dr VK Arora (Delhi), Dr D Behera (Chandigarh), Dr Agam Vora (Mumbai), Dr T Mohan Kumar (Coimbatore), Dr Narayana Pradeep (Kerala) and a team of other doctors published the white paper.
“It is a moment of pride for KGMU, UP and the country that WHO recognised the effort,” said Prof Surya Kant.
No comments:
Post a Comment